Friday, February 26, 2021
Home News Pharma News

Pharma News

Health Europa brings you the latest Pharma News the field of European Healthcare & Social Care Policy.

Single-dose Janssen COVID-19 vaccine shows 66% effectiveness

Single-dose Janssen COVID-19 vaccine shows 66% effectiveness

New data from the Phase III studies of Janssen’s single-dose COVID-19 vaccine candidate has shown 66% effectiveness in preventing coronavirus in participants. The UK has...
Novavax COVID-19 vaccine shows efficacy against Kent variant

Novavax COVID-19 vaccine shows efficacy against Kent variant

Novavax has released data from its phase III COVID-19 vaccine candidate study that demonstrates it as effective against the Kent variant of the virus. Conducted...
Malta life sciences

Malta’s ongoing commitment to the life sciences sector

Malta continues to target investment towards developing its life sciences sector and attracting international business interests
Global Ebola vaccine stockpile now established

Global Ebola vaccine stockpile now established

A global stockpile of Ebola vaccines has now been established by four of the leading health and humanitarian organisations. Led by the International Coordinating Group...
Moderna COVID-19 vaccine receives approval in UK

Moderna COVID-19 vaccine receives approval in UK

The British Government has now authorised the Moderna COVID-19 vaccine for use. The Moderna COVID-19 vaccine has become the third in Britain to gain authorisation...
Lifesaving COVID-19 treatments for NHS patients

Lifesaving COVID-19 treatments for NHS patients

Patients in intensive care units across the UK will be receiving potentially lifesaving treatments for COVID-19. The government-funded REMAP-CAP clinical trial has shown that the...
Second COVID-19 vaccine authorised by the European Commission

Second COVID-19 vaccine authorised by the European Commission

The European Commission has granted conditional marketing authorisation (CMA) for the Moderna COVID-19 vaccine – the second one to be authorised in the EU. The...
Natural compounds could disrupt future virus pandemics

Natural compounds could disrupt future virus pandemics

A team of researchers have explored the genomic and life history traits of three classes of viruses that have contributed to historical global pandemics...
WHO lists Pfizer/BioNTech COVID-19 vaccine for emergency use

WHO lists Pfizer/BioNTech COVID-19 vaccine for emergency use

As more countries across the globe begin rolling out their mass COVID-19 vaccination programmes, the World Health Organization (WHO) has now listed the Pfizer/BioNTech...
New pathway for approval of medicines in the UK

New pathway for approval of medicines in the UK

A new pathway for the approval of medicines in the UK has opened, aiming to bring closer collaboration between authorities and bodies and helping...
Treating brain disorders with new nanoparticle drug delivery system

Treating brain disorders with new nanoparticle drug delivery system

A new nanoparticle drug-delivery system could help scientists overcome the long-standing problem of delivering therapeutics across the blood-brain barrier and into the brain. Progress has...
Oxford University COVID-19 vaccine roll out begins

Oxford University COVID-19 vaccine roll out begins

The first person in the UK has now received the Oxford University and AstraZeneca COVID-19 vaccine, which has begun its NHS roll out today. The...
UK’s first investment fund dedicated to psychedelic healthcare

UK’s first investment fund dedicated to psychedelic healthcare

In a first for the UK, an investment fund dedicated to psychedelic healthcare has been launched. The new fund comes as recent rigorous clinical trials...
European Commission concludes Novavax talks for COVID-19 vaccine

European Commission concludes Novavax talks for COVID-19 vaccine

The European Commission has concluded its talks with pharmaceutical company Novavax regarding the purchase of its potential COVID-19 vaccine. The European Commission and Novavax envisaged...
Renewed collaboration to eliminate tropical diseases

Renewed collaboration to eliminate tropical diseases

A decades-long collaboration between the World Health Organization (WHO) and Sanofi has been renewed in order to sustain efforts to eliminate neglected tropical diseases. The...
Clinical trials for another COVID-19 vaccine begin in UK

Clinical trials for another COVID-19 vaccine begin in UK

Early Phase I and Phase II clinical trials have started in the UK for the Valneva COVID-19 vaccine, which is to be tested on...
Pritelivir phase III clinical trials for HSV immunocompromised patients

Pritelivir Phase III clinical trials for HSV immunocompromised patients

The medicine Pritelivir is to enter Phase III clinical trials for the treatment of immunocompromised patients who have acyclovir-resistant mucocutaneous herpes simplex virus (HSV)...
AstraZeneca to test component of Russia’s Sputnik V vaccine

AstraZeneca to test component of Russia’s Sputnik V vaccine

AstraZeneca will be testing a component of Russia’s Sputnik V COVID-19 vaccine in clinical trials of its own vaccine against the virus. Following the preliminary...
Chemotherapy-free treatment for Chronic Lymphocytic Leukaemia patients

Chemotherapy-free treatment for Chronic Lymphocytic Leukaemia patients

For the first time, patients in Scotland with previously untreated Chronic Lymphocytic Leukaemia will be able to access chemotherapy-free treatment. The Scottish Medicines Consortium has...
COVID-19 Oxford vaccine found safe and effective in Phase III trial

COVID-19 Oxford vaccine found safe and effective in Phase III trial

The first full results from the Phase III Oxford COVID-19 vaccine have found it to be safe and effective to protect against the virus. The...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest